Fresenius Medical Care AG (ETR:FME – Get Free Report)’s stock price passed below its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of €39.59 and traded as low as €38.02. Fresenius Medical Care shares last traded at €39.04, with a volume of 2,238,388 shares changing hands.
Fresenius Medical Care Trading Up 4.8%
The firm has a market cap of $12.10 billion, a price-to-earnings ratio of 18.36, a price-to-earnings-growth ratio of 0.42 and a beta of 0.94. The business has a 50 day moving average of €39.38 and a 200 day moving average of €39.59. The company has a quick ratio of 0.80, a current ratio of 1.07 and a debt-to-equity ratio of 87.31.
Fresenius Medical Care Company Profile
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
See Also
- Five stocks we like better than Fresenius Medical Care
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.
